Zef Scientific and Copia Scientific Partner to Deliver Automated Solutions for High-Throughput LC/MS Workflows: “From Sample Prep to LC/MS. Together”
Zef Scientific and Copia Scientific Partner to Deliver Automated Solutions for High-Throughput LC/MS Workflows: “From Sample Prep to LC/MS. Together”
Partnership combines laboratory automation and multivendor LC/MS expertise to help laboratories increase throughput and manage equipment and service costs.
Zef Scientific, Inc. (ZefSci), a provider of multivendor liquid chromatography/mass spectrometry (LC/MS) service and systems, and Copia Scientific, a full-service laboratory automation equipment company, today announced a partnership to provide complementary instrumentation, workflow support, and service for automated sample preparation and LC/MS analysis.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261026279820/en/
The partnership brings together the companies’ expertise to support integrated workflows—from automated sample preparation through LC/MS analysis. Copia Scientific supplies new and refurbished laboratory automation equipment, including liquid handlers, and provides multivendor service, preventive maintenance, calibration and validation, workflow integration, and method-development support. ZefSci provides refurbished LC/MS systems, multivendor service, installation and operational qualification (IQ/OQ), instrument relocation, and service contracts across major LC/MS manufacturers.
As sample volumes and study sizes increase, laboratories need sample preparation capabilities that keep pace with high-speed LC/MS analysis. The combined offerings are designed to support pharmaceutical and biotechnology companies, contract research organizations (CROs), clinical and toxicology laboratories, environmental and food testing laboratories, and high-throughput research facilities.
Together, Copia Scientific and ZefSci will offer customers a flexible, cost-conscious alternative to purchasing new equipment and relying exclusively on original equipment manufacturers (OEMs) for service. Customers can draw on both companies’ expertise to expand capacity, automate workflows, and support instruments from multiple manufacturers.
“Copia Scientific is trusted by biotechnology, pharmaceutical, CRO, and academic laboratories to deliver precision automation equipment and integrated laboratory solutions,” said Dyan Reagan, COO of Copia Scientific. “By partnering with ZefSci, we can help customers scale and automate sample preparation to better match the capabilities of today’s high-speed LC/MS systems.”
“This partnership brings together complementary expertise in laboratory automation and LC/MS instrumentation and service,” said Kevork Kaladjian, President of ZefSci. “Our North American customers will have access to a broader team of specialists to support their workflows, expand laboratory capacity, and manage equipment and service costs.”
About Copia Scientific
Copia Scientific is a multivendor laboratory instrumentation supplier with deep expertise in laboratory automation. The company helps laboratories scale efficiently with new and refurbished equipment, service, and workflow integration. From standalone instruments to integrated automation solutions, Copia Scientific builds offerings around each customer’s workflow and operational needs.
For more information, visit www.copiasci.com.
About Zef Scientific
Zef Scientific specializes in multivendor service and support for liquid chromatography and mass spectrometry instruments across the United States and Canada. Part of Shimadzu Corporation, ZefSci provides refurbished instrumentation, service contracts, preventive maintenance, qualification, and relocation services. The company supports systems from manufacturers including SCIEX, Shimadzu, Waters, Agilent, and Thermo Fisher Scientific.
For more information, visit www.zefsci.com.
Media and other inquiries:
Dyan Reagan
dyanr@copiasci.com
Media and other inquiries:
Kristina Khodova
kristina@zefsci.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20261026279820/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
5 Stocks to Buy Trading at Big Discounts
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
United States